Parkinson's Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Parkinson's Disease stocks.

Parkinson's Disease Stocks Recent News

Date Stock Title
Jul 10 QURE Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Jul 10 ANVS Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Jul 10 TEVA Argus upgrades Teva to buy, cites recent drug approvals
Jul 10 ANVS Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists
Jul 10 TEVA 3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Jul 10 QURE Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet
Jul 10 QURE uniQure (QURE) Soars on New Huntington's Disease Study Data
Jul 10 QURE uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?
Jul 9 QURE S&P 500 Edges Higher; Indivior Shares Plummet
Jul 9 QURE uniQure: Positive HD AMT-130 Treatment Data Leads To Several Other Catalysts
Jul 9 ITCI Wall Street Analysts See a 30.14% Upside in Intra-Cellular (ITCI): Can the Stock Really Move This High?
Jul 9 ANVS Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag
Jul 9 QURE Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)
Jul 9 QURE UniQure stock surges on data for Huntington’s gene therapy
Jul 9 ANVS Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
Jul 9 QURE uniQure updates trial data for Huntington’s disease therapy
Jul 9 QURE uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
Jul 8 ANVS Annovis Bio Rallies On Missed ITT Parkinson's Study Endpoints
Jul 5 ANVS Annovis Bio: A Close Look At Their Parkinson's Trial Data
Parkinson's Disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

Browse All Tags